ANTI-GBM/GOODPASTURE’S SYNDROME Page 1 of 5 Reproduction of this material requires written permission of the Vasculitis Foundation. Copyright 2022. What is anti-GBM/Goodpasture’s

Februay 13, 2018 1 Study protocol: GOOD-IDES-01, 13 February 2018 An Open-Label Phase II Study in anti-GBM disease (Goodpasture’s disease) with Adverse Renal Prognosis

Reprinted from the Archives of Surgery August 1971, Volume 103 Copyright 1971, American Medical Association Goodpasture's Syndrome Treatment With Nephrectomy and Renal

Case Report Antibody-Negative Relapse of Goodpasture Syndrome with Pulmonary Hemorrhage Charlene L. Rohm ,1 Sara Acree,2 Aseem Shrivastava,3 Asif A. Saberi,3 and Louis Lovett4

Goodpasture Syndrome: An Investigation of Disease Process, Diagnosis, Treatment, and Contribution to Intrapulmonary HemorrhageVolume 7 Diagnosis, Treatment, and Contribution

New insights into Goodpasture's syndromeYale University EliScholar – A Digital Platform for Scholarly Publishing at Yale Yale Medicine Thesis Digital Library School

Goodpasture's syndrome in a patient with two endocrine tumours R.F.T. McMahon', W. Lawler', D.J. O'Donoghue2 and F.W. Ballardie2 'Department ofPathology,

Anti-Glomerular Basement Membrane DiseaseAbstract Anti–glomerular basement membrane (anti-GBM) disease is a rare small vessel vasculitis that affects the capillary

Binding Truths: Atypical Anti-Glomerular Basement Membrane Disease Mediated by IgA Anti-Glomerular Basement Membrane Antibodies Targeting the α1 Chain of Type

Circulating Anti-Glomerular Basement Membrane Antibodies With Predominance of Subclass IgG4 and False-Negative Immunoassay Test Results in Anti-Glomerular Basement Membrane